NASDAQ:CTMX
CytomX Therapeutics Stock News
$1.59
-0.0100 (-0.625%)
At Close: Apr 26, 2024
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of GSX, GRPN and CTMX
03:10pm, Tuesday, 02'nd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 2, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Sh
NEW YORK, NY / ACCESSWIRE / June 1, 2020 / Pomerantz LLP announces that a class action lawsuit has been filed against CytomX Therapeutics Inc. ("CytomX" or the "Company") (NASDAQ:CTMX) ...
New York, New York--(Newsfile Corp. - June 1, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of CytomX Therapeutics, Inc. (NASDAQ: CTMX)
LOS ANGELES, CA / ACCESSWIRE / June 1, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc. ("Cy
New York, New York--(Newsfile Corp. - June 1, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Cyt
NEW YORK, NY / ACCESSWIRE / June 1, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against CytomX Therapeutics, Inc. ("CytomX" or "the ...
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of LBRT, ZM and CTMX
03:00pm, Monday, 01'st Jun 2020
NEW YORK, NY / ACCESSWIRE / June 1, 2020 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. S
New York, New York--(Newsfile Corp. - June 1, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CytomX Therapeutics, Inc. ("CytomX" or the "Company") (NASDAQ:
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytomX Therapeutics, Inc. (NASDAQ: CTMX) between May 17, 2018, and May 13, 2020, inclusive (the "Class Period
Is CytomX Therapeutics (CTMX) Stock a Solid Choice Right Now?
01:46pm, Monday, 01'st Jun 2020
CytomX Therapeutics (CTMX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BBBY, GRPN and CTMX
10:20am, Monday, 01'st Jun 2020
NEW YORK, NY / ACCESSWIRE / June 1, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participa
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CytomX Therapeutics, Inc. (NASDAQ: CTMX) between May 17, 20
LOS ANGELES, CA / ACCESSWIRE / May 30, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc. ("Cy
New York, New York--(Newsfile Corp. - May 29, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Cyt
LOS ANGELES, CA / ACCESSWIRE / May 29, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class-action lawsuit against CytomX Therapeutics, Inc. ("Cy
